Trials / Withdrawn
WithdrawnNCT00705770
A Multi-Dose Study With a Treatment for Open-Angle Glaucoma
- Status
- Withdrawn
- Phase
- Phase 2 / Phase 3
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- Alcon Research · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine whether Anecortave Acetate is effective for lowering intraocular pressure caused by open-angle glaucoma.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Anecortave Acetate | Low dose Sustained release depot suspension |
| DRUG | Anecortave Acetate | Middle dose Sustained release depot suspension |
| DRUG | Anecortave Acetate | High dose Sustained release depot suspension |
| DRUG | Placebo | Placebo treatment with vehicle |
Timeline
- Start date
- 2008-05-01
- Primary completion
- 2008-07-01
- Completion
- 2008-07-01
- First posted
- 2008-06-26
- Last updated
- 2012-05-30
Source: ClinicalTrials.gov record NCT00705770. Inclusion in this directory is not an endorsement.